Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
China announced its vaccine regulatory system has met...
Fosun Pharma plans a $913 million IPO on the Hong Kong...
It's earnings season, and almost every day for the past...
Sinovac Biotech reported positive results from a Phase I...
Sinovac Biotech of Beijing will begin a Phase II clinical...
China earmarked 2 trillion RMB ($309 billion) for science...
Sinovac Biotech received a production license for RabEnd,...
Newsummit Pharma and the Cleveland Bio Fund established a...
Sinovac Biotech was selected by the Beijing CDC as one of...
On October 10-11, the ChinaBio® Leadership...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
